rs1200271432

Variant summary

Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM2PP3_Strong

The NM_024963.6(FBXL18):​c.1919G>T​(p.Cys640Phe) variant causes a missense change. The variant allele was found at a frequency of 0.00000548 in 1,459,620 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000055 ( 0 hom. )

Consequence

FBXL18
NM_024963.6 missense

Scores

4
7
6

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 5.80

Publications

0 publications found
Variant links:
Genes affected
FBXL18 (HGNC:21874): (F-box and leucine rich repeat protein 18) The protein encoded by this gene is a member of a family of proteins that contain an approximately 40-amino acid F-box motif. This motif is important for interaction with SKP1 and for targeting some proteins for degradation. The encoded protein has been shown to control the cellular level of FBXL7, a protein that induces mitotic arrest, by targeting it for polyubiquitylation and proteasomal degradation. Members of the F-box protein family, such as FBXL18, are characterized by an approximately 40-amino acid F-box motif. F-box proteins interact with SKP1 through the F box, and they interact with ubiquitination targets through other protein interaction domains. [provided by RefSeq, Mar 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 6 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.958

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FBXL18NM_024963.6 linkc.1919G>T p.Cys640Phe missense_variant Exon 4 of 5 ENST00000382368.8 NP_079239.3 Q96ME1-4Q96D16

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FBXL18ENST00000382368.8 linkc.1919G>T p.Cys640Phe missense_variant Exon 4 of 5 5 NM_024963.6 ENSP00000371805.3 Q96ME1-4
FBXL18ENST00000458142.1 linkc.1568G>T p.Cys523Phe missense_variant Exon 2 of 3 2 ENSP00000405896.1 A0A994ENR3
FBXL18ENST00000415009.5 linkn.1919G>T non_coding_transcript_exon_variant Exon 4 of 7 2 ENSP00000415064.1 Q96ME1-2

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.00
AC:
0
AN:
242512
AF XY:
0.00
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000548
AC:
8
AN:
1459620
Hom.:
0
Cov.:
32
AF XY:
0.00000413
AC XY:
3
AN XY:
726076
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33458
American (AMR)
AF:
0.00
AC:
0
AN:
44546
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26106
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39662
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86016
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52262
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5764
European-Non Finnish (NFE)
AF:
0.00000720
AC:
8
AN:
1111574
Other (OTH)
AF:
0.00
AC:
0
AN:
60232
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Aug 28, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1919G>T (p.C640F) alteration is located in exon 4 (coding exon 4) of the FBXL18 gene. This alteration results from a G to T substitution at nucleotide position 1919, causing the cysteine (C) at amino acid position 640 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.21
D
BayesDel_noAF
Uncertain
0.060
CADD
Benign
23
DANN
Uncertain
0.99
Eigen
Uncertain
0.24
Eigen_PC
Benign
0.21
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.87
D
M_CAP
Benign
0.068
D
MetaRNN
Pathogenic
0.96
D
MetaSVM
Benign
-0.80
T
MutationAssessor
Benign
2.0
M
PhyloP100
5.8
PrimateAI
Uncertain
0.63
T
PROVEAN
Pathogenic
-4.7
D
REVEL
Uncertain
0.40
Sift
Uncertain
0.0010
D
Sift4G
Benign
0.082
T
Polyphen
0.85
P
Vest4
0.81
MutPred
0.80
Loss of catalytic residue at L641 (P = 0.0233);
MVP
0.81
MPC
1.4
ClinPred
0.99
D
GERP RS
4.0
gMVP
0.89
Mutation Taster
=41/59
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1200271432; hg19: chr7-5530943; API